News
Brief news reports on Tuberculosis
By
Wellcome,
Bill & Melinda Gates Foundation
Published: June 28, 2023, 5:02 p.m.·
Tags:
Vaccines,
Research and development
Wellcome and the Bill & Melinda Gates Foundation announce US$550 million funding to advance a TB vaccine candidate, M72/AS01E, through a Phase III clinical trial that could be the first in 100 years if proven effective.
Read More →
By
World Health Organization
Published: June 28, 2023, 1:53 p.m.·
Tags:
Drug-resistant TB,
Pediatrics,
Treatment
The information notes complement the updated WHO guidelines and operational handbook on the management of TB in children and adolescents released in 2022.
Read More →
By
World Health Organization
Published: June 27, 2023, 8:41 a.m.·
Tags:
Guidelines
Read More →
By
Neha Mathur
Published: June 27, 2023, 8 a.m.·
Tags:
Drug-resistant TB,
Treatment
In a recent study published in the Journal of Infection, researchers performed a systematic literature review of global treatment outcomes of extensively drug-resistant Tuberculosis.
Read More →
By
International Union Against Tuberculosis and Lung Disease
Published: June 26, 2023, 8:31 a.m.·
Tags:
Global TB response,
Public health
The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).
Read More →
By
GOV.UK
Published: June 22, 2023, 9:03 a.m.·
Tags:
TB epidemiology,
Prevention
The UK Health Security Agency released a report presenting people with TB disease notified to the enhanced surveillance scheme in England and aiming to describe the epidemiology of TB in England up to the end of 2021. It is the sixth in a series of 7 reports that will describe different aspects of TB incidence, treatment and prevention in England.
Read More →
By
Medical Xpress
Published: June 22, 2023, 7:41 a.m.·
Tags:
Diagnostics
According to the World Health Organization, each year there are approximately three million undiagnosed cases of tuberculosis (TB) globally, which are characterized as the "missing millions." In a cutting-edge study, scientists have tested a diagnostic device using dielectrophoresis that holds promise for improving TB detection and treatment of patients in high-endemic, under-resourced areas. Bringing diagnostics to the patients who need it most will help meet global targets to reduce the burden of TB. The research results appear in The Journal of Molecular Diagnostics.
Read More →
By
Terry L. Kamps, PhD
Published: June 21, 2023, 8:08 a.m.·
Tags:
Drug-resistant TB,
Scientific research
TOPLINE:
Down-regulation of plasma exosome-derived apolipoproteins APOA1, APOB, and APOC1 indicates DR-TB status and lipid metabolism regulation in pathogenesis.
Read More →
By
Ryckman et al.
Published: June 20, 2023, 8:53 a.m.·
Tags:
Global TB response
The following is a summary of “Ending tuberculosis in a post-COVID-19 world: a person-centred, equity-oriented approach,” published in the February 2023 issue of Infectious Diseases by Ryckman, et al.
Read More →
By
Refilwe Mochoari
Published: June 20, 2023, 8:35 a.m.·
Tags:
TB programs
In March this year, the director-general of the Northern Cape government, Justice Bekebeke during a parliamentary oversight visit acknowledged that about 80% of the health facilities in the province did not meet their TB performance targets of finding TB cases and ensuring successful (completed) treatment.
Read More →
Page 48 of 895 · Total posts: 10
←First
47
48
49
Last→